BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice. Sherman ME, Michalski J, Das S, Yang H, et al. Vaccine 2025;50:126779.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sherman ME, Michalski J, Das S, Yang H, et al. BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice. Vaccine 2025;50:126779.
PMID: 39946867